List of works - Sikander Ailawadhi

Assessing Patient-Reported Financial Hardship in Patients With Cancer in Routine Clinical Care

Association between race and treatment patterns and survival outcomes in multiple myeloma: A connect MM registry analysis

scientific article published on 24 July 2020

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

scientific article published on 03 April 2018

Connect MM Registry as a national reference for United States multiple myeloma patients

scientific article published on 07 November 2019

Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia

scientific article published on 08 August 2017

Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016.

scientific article published on 05 January 2017

Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials.

scientific article published on 6 July 2018

Effect of initial treatment on health-related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect® MM Registry

scientific article published on 29 October 2020

Insurance-based disparities impact survival outcomes in Waldenström macroglobulinemia within the United States

Outcomes of patients with simultaneous diagnosis of chronic lymphocytic leukaemia/small lymphocytic lymphoma and multiple myeloma

scientific article published on 05 July 2018

Pomalidomide, Bortezomib and Dexamethasone (PVD) for Patients with Relapsed, Lenalidomide Refractory Multiple Myeloma

scientific article

Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER-medicare analysis.

scientific article published on 3 November 2017

Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib

scientific article published on 4 October 2016

Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes.

scientific article published on 28 December 2017

Survival trends among non-small-cell lung cancer patients over a decade: impact of initial therapy at academic centers

scientific article published on 02 September 2018

Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cells

scientific article published on 06 August 2018

Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy

scientific article published on 10 March 2017

Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia

scientific article published on 15 October 2020

Treatment of Immunoglobulin Light Chain Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement

scientific article published on August 2015

Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities.

scientific article published on 23 January 2018

Use of KRD-PACE as Salvage Therapy in Aggressive, Relapsed/Bortezomib-Refractory Extramedullary Multiple Myeloma: A Report of Two Cases and Literature Review

scientific article published on 18 February 2020

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement.